← TrialMatch
HomeTrials

Exercise to Slow Cardiovascular Ageing Progression

In ageing, deleterious alterations in cardiovascular (CV) structure and function increase risks of ageing-related cardiovascular disease (CVD). Investigators found that these CV alterations were associated with circulating serum metabolites, suggesting a metabolic basis to CV ageing. Investigators hypothesize that modi

Condition(s)Cardiac Ageing, Exercise, Cardiovascular
StatusRecruiting
Study typeObservational
SummaryIn ageing, deleterious alterations in cardiovascular (CV) structure and function increase risks of ageing-related cardiovascular disease (CVD). Investigators found that these CV alterations were associated with circulating serum metabolites, suggesting a metabolic basis to CV ageing. Investigators hypothesize that modification of these metabolites by intervention, such as exercise, may retard CV alterations and reduce CVD in ageing.
Who can participateInclusion Criteria: * Age \>=21 years old * Outdoor ambulant Exclusion Criteria: * Wheelchair or bed-bound * Dementia * Residing in sheltered or nursing home * Cancer * Participation in ongoing clinical trials that involve interventional drugs or devices * Aneurysms * Acute infections (in the last six months) * Uncontrolled thyrotoxicosis * Neuromuscular, musculoskeletal or rheumatoid disorders that are exacerbated by exercise * Uncontrolled asthma or chronic lung disease * Restrictive lung disease
Ages21 Years to 100 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorNational Heart Centre Singapore
LocationsSingapore, Singapore, Singapore
Start date2023-05-01
NCT IDNCT05775484
Official listinghttps://clinicaltrials.gov/study/NCT05775484

🔍 Search all trials →